Cytologics, Inc. – Trademark Portfolio
Entity Type: 03
Cytologics, Inc. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 2 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 4 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include ALLVIVO. The owner is based in Birmingham, AL.
500 Beacon Parkway west
Birmingham, AL 35209
Showing of trademarks Trademarks
Trademark Classifications
Cytologics, Inc.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Scientific and technological services; industrial analysis and research services
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Cytologics, Inc. have?
Cytologics, Inc. has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 cancelled.
What trademark classes does Cytologics, Inc. file in?
Cytologics, Inc. files trademarks across 4 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 42 (Computer & Scientific), Class 9 (Computers & Electronics), Class 5 (Pharmaceuticals). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.
What are Cytologics, Inc.'s most well-known trademarks?
Cytologics, Inc.'s registered trademark portfolio includes well-known marks such as ALLVIVO. These are among 1 currently registered trademark in the portfolio.
What is Cytologics, Inc.'s trademark registration success rate?
Cytologics, Inc. has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.